Skip to main content
Log in

Genetic basis of hypertrophic cardiomyopathy in children

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

Previous investigations assessing the genetic cause of pediatric hypertrophic cardiomyopathy (HCM) found underlying genetic mutations in 50–60% of cases. The purpose of our study was to analyze whether this number can be augmented by applying next-generation sequencing and directing further diagnostics by discussing unsolved cases in a multidisciplinary board.

Methods and results

42 patients with the diagnoses of HCM made before age 18 years were treated in our center from 2000 to 2016. Genetic analysis was performed in 36 subjects, a genetic defect was detected in 29 (78%) patients. 15 individuals (42%) had pathogenic variants in genes encoding sarcomere proteins, and 5 (14%) in genes coding for components of the RAS/MAPK signaling pathway. 4 subjects (11%) had mutations in the GAA gene (Pompe disease), and 3 (8%) had Frataxin repeat expansions (Friedreich’s ataxia). One patient each showed a mutation in BAG3 and LMNA. Discussion of unsolved HCM cases after performing next-generation sequencing (28 genes) in an interdisciplinary board unraveled the genetic cause in 9 subjects (25%).

Conclusion

A definite genetic diagnosis can be reached in nearly 80% with HCM of childhood onset. Next-generation sequencing in conjunction with a multidisciplinary cooperation can enhance the diagnostic yield substantially. This may be important for risk stratification, treatment planning and genetic counseling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bharucha T, Lee KJ, Daubeney PE, Nugent AW, Turner C, Sholler GF, Robertson T, Justo R, Ramsay J, Carlin JB, Colan SD, King I, Weintraub RG, Davis AM, Investigators N (2015) Sudden death in childhood cardiomyopathy: results from a long-term national population-based study. J Am Coll Cardiol 65:2302–2310. https://doi.org/10.1016/j.jacc.2015.03.552

    Article  PubMed  Google Scholar 

  2. Burghardt A, van Buuren F, Dimitriadis Z, Grubbel T, Seggewiss H, Scholtz S, Horstkotte D, Faber L (2018) Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy. Clin Res Cardiol 107:479–486. https://doi.org/10.1007/s00392-018-1209-3

    Article  PubMed  Google Scholar 

  3. Chaowu Y, Shihua Z, Jian L, Li L, Wei F (2013) Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy. Circ Heart Fail 6:1013–1020. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000414

    Article  PubMed  Google Scholar 

  4. Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, Lurie PR, Orav EJ, Towbin JA (2007) Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation 115:773–781. https://doi.org/10.1161/CIRCULATIONAHA.106.621185

    Article  PubMed  Google Scholar 

  5. Dinshaw L, Munch J, Dickow J, Lezius S, Willems S, Hoffmann BA, Patten M (2018) The T-peak-to-T-end interval: a novel ECG marker for ventricular arrhythmia and appropriate ICD therapy in patients with hypertrophic cardiomyopathy. Clin Res Cardiol 107:130–137. https://doi.org/10.1007/s00392-017-1164-4

    Article  PubMed  Google Scholar 

  6. Force T, Bonow RO, Houser SR, Solaro RJ, Hershberger RE, Adhikari B, Anderson ME, Boineau R, Byrne BJ, Cappola TP, Kalluri R, LeWinter MM, Maron MS, Molkentin JD, Ommen SR, Regnier M, Tang WH, Tian R, Konstam MA, Maron BJ, Seidman CE (2010) Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute. Circulation 122:1130–1133. https://doi.org/10.1161/CIRCULATIONAHA.110.950089

    Article  PubMed  PubMed Central  Google Scholar 

  7. Gelb BD, Tartaglia M (2011) RAS signaling pathway mutations and hypertrophic cardiomyopathy: getting into and out of the thick of it. J Clin Investig 121:844–847. https://doi.org/10.1172/JCI46399

    Article  CAS  PubMed  Google Scholar 

  8. Hahn A, Lauriol J, Thul J, Behnke-Hall K, Logeswaran T, Schanzer A, Bogurcu N, Garvalov BK, Zenker M, Gelb BD, von Gerlach S, Kandolf R, Kontaridis MI, Schranz D (2015) Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog. Am J Med Genet Part A 167A:744–751. https://doi.org/10.1002/ajmg.a.36982

    Article  CAS  PubMed  Google Scholar 

  9. Hickey EJ, McCrindle BW, Larsen SH, Benson L, Manlhiot C, Caldarone CA, Van Arsdell GS, McCrindle BM, Williams WG (2012) Hypertrophic cardiomyopathy in childhood: disease natural history, impact of obstruction, and its influence on survival. Ann Thoracic Surg 93:840–848. https://doi.org/10.1016/j.athoracsur.2011.10.032

    Article  Google Scholar 

  10. Kearney M, Orrell RW, Fahey M, Brassington R, Pandolfo M (2016) Pharmacological treatments for Friedreich ataxia. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007791.pub4

    Article  PubMed  PubMed Central  Google Scholar 

  11. Lipshultz SE, Orav EJ, Wilkinson JD, Towbin JA, Messere JE, Lowe AM, Sleeper LA, Cox GF, Hsu DT, Canter CE, Hunter JA, Colan SD, Pediatric Cardiomyopathy Registry Study G (2013) Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry. Lancet 382:1889–1897. https://doi.org/10.1016/S0140-6736(13)61685-2

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lopes LR, Zekavati A, Syrris P, Hubank M, Giambartolomei C, Dalageorgou C, Jenkins S, McKenna W,, Plagnol V, Elliott PM (2013) Uk10k C. Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing. J Med Genet 50:228–239. https://doi.org/10.1136/jmedgenet-2012-101270

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Marian A (2008) Utilities and limitations of genetic testing for hypertropic cardiomyopathy. Expert Opin Med Diagn 2:539–546. https://doi.org/10.1517/17530059.2.5.539

    Article  PubMed  Google Scholar 

  14. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (Young) Adults. Circulation 92:785–789

    Article  CAS  PubMed  Google Scholar 

  15. Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R, Towbin JA, Seidman JG, Seidman CE (2008) Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med 358:1899–1908. https://doi.org/10.1056/NEJMoa075463

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Nugent AW, Daubeney PE, Chondros P, Carlin JB, Colan SD, Cheung M, Davis AM, Chow CW, Weintraub RG, National Australian Childhood Cardiomyopathy S (2005) Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation 112:1332–1338. https://doi.org/10.1161/CIRCULATIONAHA.104.530303

    Article  PubMed  Google Scholar 

  17. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M, Project EHF (2003) Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107:2227–2232. https://doi.org/10.1161/01.CIR.0000066323.15244.54

    Article  Google Scholar 

  18. Rubattu S, Bozzao C, Pennacchini E, Pagannone E, Musumeci BM, Piane M, Germani A, Savio C, Francia P, Volpe M, Autore C, Chessa L (2016) A next-generation sequencing approach to identify gene mutations in early- and late-onset hypertrophic cardiomyopathy patients of an italian cohort. Int J Mol Sci. https://doi.org/10.3390/ijms17081239

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sedaghat-Hamedani F, Kayvanpour E, Tugrul OF, Lai A, Amr A, Haas J, Proctor T, Ehlermann P, Jensen K, Katus HA, Meder B (2018) Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals. Clin Res Cardiol 107:30–41. https://doi.org/10.1007/s00392-017-1155-5

    Article  PubMed  Google Scholar 

  20. Ullal AJ, Abdelfattah RS, Ashley EA, Froelicher VF (2016) Hypertrophic cardiomyopathy as a cause of sudden cardiac death in the young: a meta-analysis. Am J Med 129:486–496 e482. https://doi.org/10.1016/j.amjmed.2015.12.027

    Article  PubMed  Google Scholar 

  21. Windram JD, Benson LN, Dragelescu A, Yoo SJ, Mertens L, Wong D, Grosse-Wortmann L (2015) Distribution of hypertrophy and late gadolinium enhancement in children and adolescents with hypertrophic cardiomyopathy. Congenit Heart Dis 10:E258–E267. https://doi.org/10.1111/chd.12286

    Article  PubMed  Google Scholar 

  22. Ziolkowska L, Turska-Kmiec A, Petryka J, Kawalec W (2016) Predictors of long-term outcome in children with hypertrophic cardiomyopathy. Pediatric cardiology 37:448–458. https://doi.org/10.1007/s00246-015-1298-y

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefan Rupp.

Ethics declarations

Conflict of interest

The author declares that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rupp, S., Felimban, M., Schänzer, A. et al. Genetic basis of hypertrophic cardiomyopathy in children. Clin Res Cardiol 108, 282–289 (2019). https://doi.org/10.1007/s00392-018-1354-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-018-1354-8

Keywords

Navigation